Literature DB >> 20225084

Lung cancer progression and metastasis from the prognostic point of view.

Kentaro Inamura1, Yuichi Ishikawa.   

Abstract

Lung cancer is the leading cause of cancer death in men and women worldwide. Since the occurrence of metastases in distant organs is the major reason for mortality of cancer patients, we need to elucidate the underlying mechanisms. Many studies featuring analysis of gene expression, comparative genomic hybridization and loss of heterozygosity analysis have been performed and generated support for the hypothesis that metastatic potential is acquired early in tumorigenesis. Furthermore, it is now clear that the majority of tumor cells have the potential to metastasize. Although many changes in gene expression profiles have been established retrospectively, translational research is now a high priority to enable clinical application and treatment based on laboratory findings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225084     DOI: 10.1007/s10585-010-9313-4

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  26 in total

1.  A molecular signature of metastasis in primary solid tumors.

Authors:  Sridhar Ramaswamy; Ken N Ross; Eric S Lander; Todd R Golub
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

2.  Cancer's deadly signature.

Authors:  Lance A Liotta; Elise C Kohn
Journal:  Nat Genet       Date:  2003-01       Impact factor: 38.330

3.  Metagenes and molecular pattern discovery using matrix factorization.

Authors:  Jean-Philippe Brunet; Pablo Tamayo; Todd R Golub; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-11       Impact factor: 11.205

4.  Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer.

Authors:  Liat Ein-Dor; Or Zuk; Eytan Domany
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

5.  A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

Authors:  Anil Potti; Sayan Mukherjee; Rebecca Petersen; Holly K Dressman; Andrea Bild; Jason Koontz; Robert Kratzke; Mark A Watson; Michael Kelley; Geoffrey S Ginsburg; Mike West; David H Harpole; Joseph R Nevins
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

6.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

7.  Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs.

Authors:  Takefumi Kikuchi; Yataro Daigo; Toyomasa Katagiri; Tatsuhiko Tsunoda; Koichi Okada; Soji Kakiuchi; Hitoshi Zembutsu; Yoichi Furukawa; Masafumi Kawamura; Koichi Kobayashi; Kohzoh Imai; Yusuke Nakamura
Journal:  Oncogene       Date:  2003-04-10       Impact factor: 9.867

8.  Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and non-negative matrix factorization.

Authors:  Kentaro Inamura; Takeshi Fujiwara; Yujin Hoshida; Takayuki Isagawa; Michael H Jones; Carl Virtanen; Miyuki Shimane; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Eiju Tsuchiya; Shumpei Ishikawa; Hiroyuki Aburatani; Hitoshi Nomura; Yuichi Ishikawa
Journal:  Oncogene       Date:  2005-10-27       Impact factor: 9.867

9.  Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.

Authors:  Zhifu Sun; Marie-Christine Aubry; Claude Deschamps; Randolph S Marks; Scott H Okuno; Brent A Williams; Hiroshi Sugimura; V Shane Pankratz; Ping Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

10.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.

Authors:  A Bhattacharjee; W G Richards; J Staunton; C Li; S Monti; P Vasa; C Ladd; J Beheshti; R Bueno; M Gillette; M Loda; G Weber; E J Mark; E S Lander; W Wong; B E Johnson; T R Golub; D J Sugarbaker; M Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

View more
  13 in total

1.  Activated platelets interact with lung cancer cells through P-selectin glycoprotein ligand-1.

Authors:  Liang Gong; Yun Cai; Xiangdong Zhou; Heping Yang
Journal:  Pathol Oncol Res       Date:  2012-04-26       Impact factor: 3.201

2.  Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer.

Authors:  Yongwen Li; Ying Li; Jinghao Liu; Yaguang Fan; Xin Li; Ming Dong; Hongyu Liu; Jun Chen
Journal:  Cancer Biol Ther       Date:  2016-01-30       Impact factor: 4.742

Review 3.  Genomics screens for metastasis genes.

Authors:  Jinchun Yan; Qihong Huang
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

4.  Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1).

Authors:  Yang Jiao; Ke-kang Sun; Lin Zhao; Jia-ying Xu; Li-li Wang; Sai-jun Fan
Journal:  Acta Pharmacol Sin       Date:  2011-12-12       Impact factor: 6.150

5.  Transducer of erbB2.1 is a potential cellular target of gefitinib in lung cancer therapy.

Authors:  Ke-Kang Sun; Yang Yang; Lin Zhao; Li-Li Wang; Yang Jiao
Journal:  Oncol Lett       Date:  2012-10-15       Impact factor: 2.967

6.  MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3.

Authors:  Hongwei Liang; Xin Yan; Yi Pan; Yongsheng Wang; Nan Wang; Limin Li; Yuan Liu; Xi Chen; Chen-Yu Zhang; Hongwei Gu; Ke Zen
Journal:  Mol Cancer       Date:  2015-03-11       Impact factor: 27.401

7.  Role of α7-nicotinic acetylcholine receptor in nicotine-induced invasion and epithelial-to-mesenchymal transition in human non-small cell lung cancer cells.

Authors:  Chun Zhang; Xu-Ping Ding; Qing-Nan Zhao; Xin-Jie Yang; Shi-Min An; Hao Wang; Lu Xu; Liang Zhu; Hong-Zhuan Chen
Journal:  Oncotarget       Date:  2016-09-13

8.  Increased HSP27 correlates with malignant biological behavior of non-small cell lung cancer and predicts patient's survival.

Authors:  Baowei Sheng; Congcong Qi; Bing Liu; Yong Lin; Tian Fu; Qingdi Zeng
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

9.  Does hypermethylation of CpG island in the promoter region of the E-cadherin gene increase the risk of lung cancer? A meta-analysis.

Authors:  Zhenfeng Sun; Gongzhe Liu; Ning Xu
Journal:  Thorac Cancer       Date:  2018-11-03       Impact factor: 3.500

10.  Diagnosis of Distant Metastasis of Lung Cancer: Based on Clinical and Radiomic Features.

Authors:  Hongyu Zhou; Di Dong; Bojiang Chen; Mengjie Fang; Yue Cheng; Yuncun Gan; Rui Zhang; Liwen Zhang; Yali Zang; Zhenyu Liu; Hairong Zheng; Weimin Li; Jie Tian
Journal:  Transl Oncol       Date:  2017-11-20       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.